-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA(TM)

Dow Jones·08/27/2026 20:05:00

Please log in to view news